Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing
Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.
Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155